Skip to Main Content

Paper Details

Alpha-1 adrenergic receptor antagonists to prevent hyperinflammation and death from lower respiratory tract infection.
Elife
17
2021
1-AR, ARD, Alpha-1 adrenergic receptor, COVID-19, Coronavirus disease 2019, acute respiratory distress, alpha-1 adrenergic receptor, death, hyperinflammation, lower respiratory tract infection, mice, multi-organ failure, patients, pneumonia, respiratory distress syndrome, viral pneumonia
Author NameAffiliation
Akinobu NishimuraJohns Hopkins Bloomberg School of Public Health at Johns Hopkins University
Brian CaffoJohns Hopkins Bloomberg School of Public Health at Johns Hopkins University
Nickolas Papadopoulosand the Howard Hughes Medical Institute at The Johns Hopkins Kimmel Cancer Center
Kenneth W Kinzlerand the Howard Hughes Medical Institute at The Johns Hopkins Kimmel Cancer Center
Bert Vogelsteinand the Howard Hughes Medical Institute at The Johns Hopkins Kimmel Cancer Center
Chetan BettegowdaThe Johns Hopkins University School of Medicine
Chetan Bettegowdaand the Howard Hughes Medical Institute at The Johns Hopkins Kimmel Cancer Center
Brett D MenshHoward Hughes Medical Institute
Joshua T VogelsteinInstitute for Computational Medicine, The Johns Hopkins University
Joshua T VogelsteinJohns Hopkins Bloomberg School of Public Health at Johns Hopkins University
Joshua T VogelsteinInstitute for Computational Medicine, The Johns Hopkins University
Joshua T VogelsteinJohns Hopkins Bloomberg School of Public Health at Johns Hopkins University
  • 1 - 12

Datasets

Release 1.2